Latest Market Launch News

NoviqTech unveils advanced quantum-powered platforms to enhance emissions tracking and sustainability reporting across multiple industries, targeting booming carbon and recycling markets.

Nanosonics has secured FDA clearance for its next-generation trophon3 device and trophon2 Plus software upgrade, setting the stage for significant growth in the US medical disinfection market.

Vitrafy Life Sciences reported a 75% increase in FY25 sales driven by aquaculture and human health sectors, progressing its cryopreservation technology towards commercialisation in both unregulated and regulated markets in FY26.

PainChek Limited has secured a A$7.5 million placement to fuel its international expansion, with US FDA clearance for its adult pain assessment app expected imminently. The company reports strong license growth and a 26% revenue increase year-on-year.

Firebird Metals is developing Lithium Manganese Rich cathode materials to target next-generation solid-state batteries, aiming to strengthen its position in the evolving EV and high-energy battery markets.

LTR Pharma has initiated commercial distribution of its nasal spray SPONTAN through Australia's Symbion pharmacy network and is advancing ROXUS development for a US launch in early 2026, while expanding its pipeline with a new intranasal treatment for swallowing disorders.

Adslot Ltd has activated its StoreFront digital advertising platform across multiple international markets, driving $148.9 million in total transaction value for FY25 amid significant cost savings and a growing sales pipeline.

PEXA’s UK arm has secured a formal commitment from NatWest to implement its digital platform for remortgage and sale & purchase transactions, marking a pivotal step in PEXA’s UK expansion.

PPK Group’s majority-owned PowerPlus Energy launches two Clean Energy Council-approved batteries eligible for the Australian Government’s new Cheaper Home Batteries Program rebates, positioning itself to capture a significant share of the emerging residential energy storage market.

Orthocell Limited has reported a record FY2025 revenue of A$9.19 million, driven by strong sales of its nerve repair product Remplir™ in Australia and a promising US market launch following FDA clearance.

Cochlear Limited has secured FDA approval for its latest Nucleus Nexa System and Kanso 3 sound processors, setting the stage for a US market debut in early FY26.

Terragen Holdings has been granted a US patent for its microbial feed supplements, reinforcing its position in the animal probiotics market and supporting plans for US market entry.